Alphadyne Asset Management LP Bristol Myers Squibb CO Transaction History

Alphadyne Asset Management LP

  • $672 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$48.48 - $57.85 $151,887 - $181,244
3,133 Added 32.01%
12,921 $662,000
Q3 2023

Nov 14, 2023
BUY
$57.89 - $64.73 $295,239 - $330,123
5,100 Added 108.79%
9,788 $568,000
Q2 2023

Aug 14, 2023
BUY
$63.71 - $70.74 $298,672 - $331,629
4,688 New
4,688 $299,000

Others Institutions Holding BMY

# of Institutions
2,536
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $126B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Alphadyne Asset Management LP Portfolio

Follow Alphadyne Asset Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alphadyne Asset Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Alphadyne Asset Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email